374 related articles for article (PubMed ID: 16267663)
1. Ab initio model studies of copper binding to peptides containing a His-His sequence: relevance to the beta-amyloid peptide of Alzheimer's disease.
Raffa DF; Gómez-Balderas R; Brunelle P; Rickard GA; Rauk A
J Biol Inorg Chem; 2005 Dec; 10(8):887-902. PubMed ID: 16267663
[TBL] [Abstract][Full Text] [Related]
2. Ab initio modelling of the structure and redox behaviour of copper(I) bound to a His-His model peptide: relevance to the beta-amyloid peptide of Alzheimer's disease.
Raffa DF; Rickard GA; Rauk A
J Biol Inorg Chem; 2007 Feb; 12(2):147-64. PubMed ID: 17013614
[TBL] [Abstract][Full Text] [Related]
3. Using N-Terminal Coordination of Cu(II) and Ni(II) to Isolate the Coordination Environment of Cu(I) and Cu(II) Bound to His13 and His14 in Amyloid-β(4-16).
Pushie MJ; Stefaniak E; Sendzik MR; Sokaras D; Kroll T; Haas KL
Inorg Chem; 2019 Nov; 58(22):15138-15154. PubMed ID: 31657204
[TBL] [Abstract][Full Text] [Related]
4. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease.
Ma QF; Hu J; Wu WH; Liu HD; Du JT; Fu Y; Wu YW; Lei P; Zhao YF; Li YM
Biopolymers; 2006 Sep; 83(1):20-31. PubMed ID: 16615111
[TBL] [Abstract][Full Text] [Related]
5. New insights into the coordination of Cu(II) by the amyloid-B 16 peptide from Fourier transform IR spectroscopy and isotopic labeling.
El Khoury Y; Dorlet P; Faller P; Hellwig P
J Phys Chem B; 2011 Dec; 115(49):14812-21. PubMed ID: 22026330
[TBL] [Abstract][Full Text] [Related]
6. pH-Dependent Cu(II) coordination to amyloid-β peptide: impact of sequence alterations, including the H6R and D7N familial mutations.
Alies B; Eury H; Bijani C; Rechignat L; Faller P; Hureau C
Inorg Chem; 2011 Nov; 50(21):11192-201. PubMed ID: 21980910
[TBL] [Abstract][Full Text] [Related]
7. An integrated study of the affinities of the Aβ16 peptide for Cu(I) and Cu(II): implications for the catalytic production of reactive oxygen species.
Young TR; Kirchner A; Wedd AG; Xiao Z
Metallomics; 2014 Mar; 6(3):505-17. PubMed ID: 24493126
[TBL] [Abstract][Full Text] [Related]
8. Computational studies of Cu(II)/Met and Cu(I)/Met binding motifs relevant for the chemistry of Alzheimer's disease.
Gómez-Balderas R; Raffa DF; Rickard GA; Brunelle P; Rauk A
J Phys Chem A; 2005 Jun; 109(24):5498-508. PubMed ID: 16839078
[TBL] [Abstract][Full Text] [Related]
9. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
10. Local structure and global patterning of Cu2+ binding in fibrillar amyloid-β [Aβ(1-40)] protein.
Gunderson WA; Hernández-Guzmán J; Karr JW; Sun L; Szalai VA; Warncke K
J Am Chem Soc; 2012 Nov; 134(44):18330-7. PubMed ID: 23043377
[TBL] [Abstract][Full Text] [Related]
11. The amyloid-beta peptide of Alzheimer's disease binds Cu(I) in a linear bis-his coordination environment: insight into a possible neuroprotective mechanism for the amyloid-beta peptide.
Shearer J; Szalai VA
J Am Chem Soc; 2008 Dec; 130(52):17826-35. PubMed ID: 19035781
[TBL] [Abstract][Full Text] [Related]
12. Structures and stabilities of Fe2+/3+ complexes relevant to Alzheimer's disease: an ab initio study.
Alí-Torres J; Rodríguez-Santiago L; Sodupe M; Rauk A
J Phys Chem A; 2011 Nov; 115(45):12523-30. PubMed ID: 21678945
[TBL] [Abstract][Full Text] [Related]
13. Insights into the oxygen-based ligand of the low pH component of the Cu(2+)-amyloid-β complex.
Gomez-Castro CZ; Vela A; Quintanar L; Grande-Aztatzi R; Mineva T; Goursot A
J Phys Chem B; 2014 Aug; 118(34):10052-64. PubMed ID: 25090035
[TBL] [Abstract][Full Text] [Related]
14. Substantial contribution of the two imidazole rings of the His13-His14 dyad to Cu(II) binding in amyloid-β(1-16) at physiological pH and its significance.
Shin BK; Saxena S
J Phys Chem A; 2011 Sep; 115(34):9590-602. PubMed ID: 21491887
[TBL] [Abstract][Full Text] [Related]
15. Modeling the Cu+ binding in the 1-16 region of the amyloid-β peptide involved in Alzheimer's disease.
Furlan S; Hureau C; Faller P; La Penna G
J Phys Chem B; 2010 Nov; 114(46):15119-33. PubMed ID: 21038888
[TBL] [Abstract][Full Text] [Related]
16. Zn2+'s ability to alter the distribution of Cu2+ among the available binding sites of Aβ(1-16)-polyethylenglycol-ylated peptide: implications in Alzheimer's disease.
Damante CA; Ösz K; Nagy Z; Grasso G; Pappalardo G; Rizzarelli E; Sóvágó I
Inorg Chem; 2011 Jun; 50(12):5342-50. PubMed ID: 21612223
[TBL] [Abstract][Full Text] [Related]
17. Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques.
Syme CD; Nadal RC; Rigby SE; Viles JH
J Biol Chem; 2004 Apr; 279(18):18169-77. PubMed ID: 14978032
[TBL] [Abstract][Full Text] [Related]
18. Binding affinities for models of biologically available potential Cu(II) ligands relevant to Alzheimer's disease: an ab initio study.
Rickard GA; Gomez-Balderas R; Brunelle P; Raffa DF; Rauk A
J Phys Chem A; 2005 Sep; 109(37):8361-70. PubMed ID: 16834228
[TBL] [Abstract][Full Text] [Related]
19. X-ray Absorption Spectroscopy Investigations of Copper(II) Coordination in the Human Amyloid β Peptide.
Summers KL; Schilling KM; Roseman G; Markham KA; Dolgova NV; Kroll T; Sokaras D; Millhauser GL; Pickering IJ; George GN
Inorg Chem; 2019 May; 58(9):6294-6311. PubMed ID: 31013069
[TBL] [Abstract][Full Text] [Related]
20. Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease.
Syme CD; Viles JH
Biochim Biophys Acta; 2006 Feb; 1764(2):246-56. PubMed ID: 16266835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
